DNA ligase: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 18: Line 18:


Human LigD IV contains several domains: DNA-binding domain (residues 1-240); adenylation domain (residues 268-405) and the ca. 100 amino acid long BRCT motifs (residues 654-911).  In the ATP-dependent LigD the ATP binds between 2 symmetry related LigD molecules.
Human LigD IV contains several domains: DNA-binding domain (residues 1-240); adenylation domain (residues 268-405) and the ca. 100 amino acid long BRCT motifs (residues 654-911).  In the ATP-dependent LigD the ATP binds between 2 symmetry related LigD molecules.
 
*<scene name='44/443730/Cv/3'>ATP binding site</scene> in ATP-dependent DNA ligase from ''S. solfataricus'' ([[2hix]]). <ref>PMID:17052461</ref>
</StructureSection>
</StructureSection>



Revision as of 18:15, 4 January 2016

ATP-dependent DNA ligase complexed with ATP 2hix

Drag the structure with the mouse to rotate

3D Structures of DNA ligase

Updated on 04-January-2016

REFERENCES

Elevated expression of DNA ligase I in human cancers., Sun DY, Urrabaz R, Nguyen M, Marty J, Stringer S, Cruz E, Medina-Gundrum L, Weitman S., Clinical Cancer Research. 2001; 7(12):4143-4148.
Replication failure, genome instability, and increased cancer susceptibility in mice with a point mutation in the DNA ligase I gene., Harrison C, Ketchen AM, Redhead NJ, O'Sullivan MJ, Melton DW., Cancer Research. 2002; 62(14):4065-4074.

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Michal Harel